Bone marrow transplantation for therapy-induced acute myeloid leukemia in children with previous lymphoid malignancies (original) (raw)
- Original Article
- Published: 30 September 1999
Acute leukaemia
Bone Marrow Transplantation volume 24, pages 735–739 (1999)Cite this article
- 359 Accesses
- 31 Citations
- Metrics details
Abstract
Twenty-one children who developed therapy-related acute myeloid leukemia after treatment for acute lymphoblastic leukemia received allogeneic bone marrow transplants between January 1990 and June 1997. All had previously received epipodophyllotoxin-containing regimens and 11 had cytogenetic abnormalities involving 11q23. Induction chemotherapy was given to 13 patients and eight patients went directly to BMT. Eleven received marrow from matched siblings, eight from matched unrelated donors and two from haploidentical family members. Conditioning regimens included cyclophosphamide (CY), cytarabine, and total body irradiation. Four patients are alive disease-free between 1118 and 1825 days post-BMT resulting in a 3-year DFS of 19%. Ten patients relapsed at a median of 150 days (range 30–664 days) post-BMT and all eventually died of disease. Seven patients died of regimen-related toxicity. The outlook for patients with therapy-related AML/MDS remains poor and more effective therapy is needed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Author notes
- GA Hale
Present address: Division of Blood and Marrow Transplantation, University of Kentucky, 800 Rose Street, Lexington, 40536, KY, USA
Authors and Affiliations
- Division of Bone Marrow Transplantation, St Jude Children’s Research Hospital, Memphis, TN, USA
GA Hale, HE Heslop, LC Bowman, RA Rochester, MK Brenner & RA Krance - Department of Pediatrics, University of Tennessee College of Medicine, Memphis, TN, USA
HE Heslop, LC Bowman, C-H Pui, MK Brenner & RA Krance - Division of Leukemia, Department of Hematology/Oncology, St Jude Children’s Research Hospital, Memphis, TN, USA
C-H Pui - Center for Cell and Gene Therapy, Baylor College of Medicine, 1102 Bates St, Suite 1140, Houston, 77030, TX, USA
HE Heslop, MK Brenner & RA Krance
Authors
- GA Hale
You can also search for this author inPubMed Google Scholar - HE Heslop
You can also search for this author inPubMed Google Scholar - LC Bowman
You can also search for this author inPubMed Google Scholar - RA Rochester
You can also search for this author inPubMed Google Scholar - C-H Pui
You can also search for this author inPubMed Google Scholar - MK Brenner
You can also search for this author inPubMed Google Scholar - RA Krance
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Hale, G., Heslop, H., Bowman, L. et al. Bone marrow transplantation for therapy-induced acute myeloid leukemia in children with previous lymphoid malignancies.Bone Marrow Transplant 24, 735–739 (1999). https://doi.org/10.1038/sj.bmt.1701962
- Received: 16 February 1999
- Accepted: 25 April 1999
- Published: 30 September 1999
- Issue Date: 01 October 1999
- DOI: https://doi.org/10.1038/sj.bmt.1701962